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1. Oligomycin-resistant mutants of Saccharomyces cerevisiae strain D273-10B/A1 have been 
assigned to three previously defined mitochondrial genetic loci, olil, oli2 and oli3. Standard crosses 
of o/iJ-resistant mutants yielded a low percentage of sensitive recombinants indicating that the 
mutations were in closely linked but separate alleles. 
2. The oligomycin-resistant mutants were used to study the amino acid sequence of the dicyclo-
hexylcarbodiimide-binding subunit of the mitochondrial ATPase complex. Two different amino 
acid substitutions have been identified in the dicyclohexylcarbodiimide-binding protein of a/il-
resistant mutants: leucine/phenylalanine at residue 53 or cysteinejserine at residue 65. The protein 
of the single o/i3-resistant strain examined had a leucinejvaline exchange in residue 57. No differ-
ences were noted in the dicyclohexylcarbodiimide-binding protein of the oli2-resistant mutant when 
the amino acid composition of cyanogenbromide fragments as well as a partial sequence were com-
pared with the wild type. These data indicate that the olil and o/i3locus are in the structural gene of 
the dicyclohexylcarbodiimide-binding protein and they suggest that the oli2 locus is in some other 
still unidentified mitochondrial gene. 
3. Aminoacid sequence data have also been obtained for the dicyclohexylcarbodiimide-binding 
protein of a revertant of an A TPase-deficient pho2 mutant. The protein of the revertant strain was 
ascertained to have a serinefleucine exchange at residue 42. The localization of the pho2 locus in 
the structural gene of the dicyclohexylcarbodiimide-binding protein is in agreement with previous 
evidence that mutations in the pho2 and olil loci are genetically linked. 
4. The frequencies of recombination among the olil and oli3 resistant mutants have been related 
to the distances of the amino acids affected by the mutations. lt is concluded that mutations in 
adjacent amino acids recombine with a frequency of 0.01 %. 
As a result of recent studies in severallaboratories 
[1- 5] it has become evident that the mitochondrial 
genome of Saccharomyces cerevisiae codes for some 
if not all the proteins that are synthesized on mito-
chondrial ribosomes. This set of proteins includes 
three subunits of cytochrome oxidase [6, 7], four sub-
units of the oligomycin-sensitive ATPase [8] and cyto-
chrome b [9]. The identification of presumptive mito-
chondrial gene products has been based largely on 
correlative sturlies of mit- mutations which results in 
a loss or an alteration of the molecular size of specific 
mitochondrial translation products (mit- mutants 
have point mutations or small deletions in mitochon-
drial DNA that result in respiratory deficiency. Muta-
tions in oxi loci cause a deficiency of cytochrome 
oxidase, cob (box) loci of cytochrome b and pho Ioci 
of the ATPase.) For example numerous mutations in 
the cob ( or box) loci have been found to cause a 
reduction in the molecular weight of cytochrome b 
[2- 4 ]. Similarly, mutations in oxil and oxi3 can cause 
the appearance of altered forms of subunits 2 and 1 
of cytochrome oxidase, respectively [5]. In the case 
of the A TPase, the evidence so far has also been of 
an indirect nature. Certain oligomycin-resistant mu-
tants in the alillocus exhibit a modified dicyclohexyl-
carbodiimide-binding subunit which fails to form the 
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Table 1. Namesand genotypes of strains 
Name Genotypes 
0273-lOB/Al 
0273-1 OB/ A2 1 
0273-10B/A31 
0273-10B/A32 
0273-10B/A33 
0273-1 OB/A48 
D273-10B/A68 
CB-11 
CD21-1A 
C031-3A 
CD32-9A 
C033-7A 
022 
D22/Al5 
D22/A16 
D22/V61 
nuclear rnito-
chondrial 
IX, met g+, w+ 
IX, met g+, w+, 0~2s. 
P:26, E~24 
a, met Q+, w+, Ofot 
oc, met g+, w+, Ofu2 
cx,met (!+, w+, Ofo3 
a, met g+, w+, Ofts 
IX, met g+, w+, or.9 
a, adel (]+, (()+ 
a, adel e+. w+, 
a, adel e+, w+, Ofot 
a, adel o+, w+, Ofo2 
a, adel (!+, w+, Ofoj 
a, adel g+, w+ 
a, ade2 e+. w+, or44 
a, ade2 g+, w+, or45 
a, ade2 g+, w+, v~, 
Refercnces 
[10] 
[10] 
(this study) 
(this study) 
(this study) 
(this study) 
(this study) 
from Dr R. Needleman 
(D273-10B/A21 X CB11) 
(0273-10B/A31 X CB11) 
(D273-10B/A32 X CB11) 
(D273-10B/A33 X CB11) 
[12] 
[12] 
[12] 
[13] 
M339-45/R17 a, met g+, w+, rnit94s [14] 
hexamer usually present in wild-type oligomycin-
sensitive strains [10]. (The dicyclohexylcarbodimide-
binding protein has also been referred to as the pro-
teolipid or subunit 9 of the ATPase complex.) 
The determination of the complete amino acid 
sequence of the wild-type dicyclohexylcarbodiimide-
binding protein (unpublished) has made it feasible tQ 
extend the structural analyses to bther strains carrying 
mutations in the olil, oli2 and oli3 loci and thereby di-
rectly test whether these mitochondrial genetic markers 
are associated with the structural gene of this ATPase 
subunit. In this comrnunication we present evidence 
that mutations which can be genetically ascribed to 
the olil and oli3 loci Iead to single amino acid sub-
stitutions in the dicyclohexylcarbodiimide-binding 
protein and are therefore included within the struc-
tural gene. Similar data have been obtained for a 
revertant of a mutant in the pho2 locus. The identifi-
cation of three genetic markers with a structural gene 
of yeast mitochondrial DNA should be useful for 
future studies on the isolation and sequencing of 
the gene. 
MATERIALS AND METHODS 
Isolation of Oligomycin-Resistant Strains 
Some of the oligomycin-resistant strains were ob-
tained from the wild-type sensitive haploid D273-
10B/A1. A freshly grown culture of D273-10B/A1 
(106 -107 cells) was plated on R medium (1% yeast 
extract, 2 :%; peptone, 3% glycerol, 2% agar, 5 Jlg 
rutamycin/ml). Spontaneaus resistant mutants were 
collected after 4- 5 days of incubation of the plates 
Mutant ATPase Proteolipid 
at 30 °C. The resistant strains were purified and the 
mutations ascertained tobe mitochondrial by mitotic 
and meiotic segregation tests. In both tests, the 
mutants were crossed to the oligornycin-sensitive 
haploid Saccharomyces carlsbergensis CB11. After 
20-30 generations of growth on W 0 medium (W icker-: 
ham's medium without amino acids, supplemented 
with 2% glucose), the prototrophically selected di-
ploids were spread for single colonies on WO plates 
and replicated on rutamycin medium. Mutants yielding 
an equal distribution of rutamycin-sensitive and ruta-
mycin-resistant segregants were further checked to be 
mitochondrially inherited by tetrad dissection of a 
single resistant diploid colony. In all cases 4:0 segrega-
tion ratios ofthe meiotic spare progeny were obtained. 
Some of the resistant strains were constructed by 
rnating the original mutants toS. carlsbergensis CB11 
and isolating an 'a'-mating-type oligomycin-resistant 
spore after tetrad dissection. Other standard oligo-
mycin-resistant strains were kindly provided by Drs 
D. Griffiths and B. Lancashire. Table 1 lists the geno-
types and sources of the various strains used. 
Recombination of 0/igomycin-Resistant Alleles 
Oligomycin-resistant haploid strains in the oppo-
site mating type and with complementary auxo-
trophies were manually mated on YPD plates (1 % 
yeast extract, 2% peptone, 2% glucose, 2% agar). 
After overnight incubation at 30 oc, the mating patch 
was replicated on WO medium and incubated for an 
additional two days. The prototrophically selected 
diploids were spread for single colanies on WO 
medium and after 2-3 days of growth replicated on 
YEPG medium (1% yeast extract, 2% ethanol, 3% 
glycerol, 2% agar) and R medium. Colaniesthat grew 
on the glycerol but not the rutamycin plates were 
scored as oligomycin-sensitive recombinants. The re-
combination frequency was equated to the percentage 
of oligomycin-sensitive colanies in the total glycerol-
positive population. 
Preparation of Submitochondrial Particles 
and of the Dicyclohexylcarbodiimide-Binding Protein 
Overnight cultures of the wild-type and mutant 
strains (10 ml) were inoculated into 10 I of liquid 
YPD medium in a 14-1 fermenter cup (New Brunswick 
Microferm). The culture was grown to stationary 
phase by vigorous aeration at 30 oc for 17 h. The 
cells were disrupted with glass beads in a Bronwill 
homogenizer and mitochondria prepared by previ-
ously published procedures [15]. The mitochondria 
were suspended in 0.25 sucrose, 10 mM Iris-acetate 
pH 7.5 and sonically irradiated for 30 s in a Raytheon 
10-kHz Sonic Oscillator. The submitochondrial par-
ticles were collected by centrifugation at 79000 x g for 
W. Sebald, E. Wachter, and A. Tzagoloff 
60 min, suspended in 10 mM Tris-acetate pH 7.5 at 
a protein concentration of 20-25 mg/ml and used 
directly for the isolation of the proteolipid. Under 
these conditions the yield of submitochondrial par-
ticles was 0.8-1 g of protein. When larger amounts 
of proteolipid were required, cells were grown in 100 I 
of YPD medium and mitochondria were prepared by 
the liquid nitrogen method of cell disruption [16]. 
The procedure for the purification of the dicyclo-
. hexylcarbodiimide-binding protein originally de-
scribed by Sierra and Tzagoloff [17] was modified. 
The following protocol was used, starting from 1 g 
of submitochondrial particles. The suspension of par-
ticles (about 20 mg/ml) was added to 9 vol. of ice-cold 
methanol. Following 10 min of stirring, the mixture 
was centrifuged at 2000 x g for 10 min, and the pellet 
was homogenized with 50 ml of chloroform/methanol 
(2/1) and the mixture centrifuged at 10000 x g for 
10 min in stainless steel bottles. The supernatant was 
saved and the pellet extracted two additional times 
with the same volumes of chloroform/methanol (2/1 ). 
The combined extracts were reduced to near dryness 
in a flash evaporator and the residue dissolved in 
10 ml of chloroformjmethanol (2/1). The proteolipid 
was precepitated with 5 vol. of cold ether and cen-
trifuged at 10000 x g for 10 min. The ether precipita-
tion was usually repeated three additional times. We 
have noted that following ether precipitation some 
material failed to be dissolved in chloroformjmethanol 
and was removed by centrifugation. The yield of pro-
teolipid from 1 g of particles was. about 2 mg which 
was sufficient for the amino acid analysis and se-
quencing of the 17-residue cyanogen bromide frag-
ment. 
Preparation and Separation 
of Cyanogen Bromide Fragments 
The purified dicyclohexylcarbodiimide-binding 
protein was dissolved in 0.4 ml of a 1 M solution of 
cyanogen bromide in 98% formic acid. Following 
dissolution of the protein 0.1 ml H20 was added and 
the cJeavage reaction was carried out overnight at 
room temperature. The mixture was dried in a ftash 
evaporator, the residue dissolved in 0.5 ml of 80% 
formic acid. The three fragments generated by cyano-
gen bromide were separated on a Bio-Gel P-30 
column developed with 80% formic acid. The details 
of this procedure are described in a forthcoming 
paper. 
Amino Acid Sequence Determinations 
All sequencing was done on the 17-residue frag-
ment coupled through the C-terminal homoserine 
Iactone to 3-aminopropyl glass. The details of the 
solid-phase sequencing are described in a forth-
coming paper. 
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Table 2. Phenotypes of strains used .for the analysis of the dicydo-
hexylcarbodiimide-binding profein 
Strain M339-45/R17 was isolated as a spontaneaus revertant of 
the mit- mutant M339-45 which was determined to have a mutation 
in the pho2 locus. Since the parent (0273-lOB/Al) is a wild-type 
antibiotic-sensitive strain, the oligomycin resistance of the revertant 
is the result of the second correcting mutation [14] 
Strain Affected Phenotype 
locus 
D273-10B/A1 none sensitive 
D273-10B/A21 olil oligomycin resistant 
D273-10B/A31 o/il oligomycin resistant 
D273-10B/A32 olil oligomycin resistant 
D273-10B/A33 olil oligomycin resistant 
D273-10B/A48 o/i2 oligomycin resistant 
D273-10B/A68 oli3 oligomycin and venturiCidin 
rasistant 
M339-45/R t 7 pho2 oligomycin resistant 
Amino Acid Analyses 
The fragments were hydrolyzed in 6 M HCl for 
24 hat 105 °C. Aminoacid analyses were performed 
in a Durrum amino acid analyser (model 500). 
RESULTS 
Oligomycin-Resistant Strains Used 
for Structural Analysis 
of the Dicyclohexylcarbodiimide-Binding Protein 
Since the amino acid sequence of the dicyclohexyl-
carbodiimide-binding protein of the oligomycin-sensi-
tive haploid D273-10B/A1 bad been determined [11], 
all the proteins examined in this study were obtained 
from spontaneaus oligomycin-resistant mutants of 
this strain. The mutants chosen represented the four 
mitochondrial genetic loci, olil, oli2, oli3 and pho2, 
based on their phenotypes (Table 2) and recombina-
tion data with standard oligomycin-resistant strains 
isolated in other laboratories (Table 4). 
Recombination Frequencies 
of Oligomycin-Resistant Mutants 
in lntra-Locus and lnter-Locus Crosses 
Even though the strains used for the measurement 
of recombination frequencies, were not isogenic either 
in their nuclear or mitochondrial DNA, the segregation 
of the resistance markers indicated that the input of 
mitochondrial DNA [18] in crosses involving CB11, 
D22 and D273-10B/A1 were not significantly differ-
ent. This is shown in Table 3 where crosses of the 
wild-type CB11 and D22 to independent oligomycin-
resistant isolates of D273-10B/A1 are seen to yield 
an approximately equal proportion of sensitive and 
resistant diploid segregents. 
The mutated loci in the resistant strains derived 
from D273-1 OB/ A1 were studied by quantitative re-
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Table 3. Segregation o.f oligomycin resistance in crosses involving 
D22, CBJ 1 and D273 
Cross 
CBll X 0273-10B/A21 
022 X 0273-10B/A21 
022 X D273-10B/A31 
022 X D273-10B/A32 
022 X D273-10BiA33 
Colonies 
scored 
543 
144 
202 
194 
191 
Nurober Sensi-
of oligo- tives 
roycin 
resistant 
colonies 
% 
263 48.4 
61 42.4 
115 56.9 
94 48.5 
104 54.5 
. Table 4. lntra-locus and inter-locus crosses 
Crosses 
o/iJR X ofiJR 
0273-10B/A21 X D22/A16 
D273-10B/A21 xCD31-3A 
D273-10B/A21 X CD3i-9A 
D273-10B/A21 X CD33-7A 
D22/A16 X D273-10B/A31 
D22/A16 X D273-10B/A32 
D22/A16 X D273-10B/A33 
D273-10B/A31 X CD32-9A 
D273-10B/A31 X C033-7A 
D273-10B/A32 X CD33-7A 
ofi2R X ofi]R 
D273-10B/A48 X D22/Al5 
oJiJR X ofi]R 
D273-10B/A68 X D22/V61 
ofi2R X oJifR 
D22/A15 X D273-10B/A21 
D22/A15 X 0273-10B/A31 
D22/A15 X 0273-10B/A32 
D22/A15 X D273-10B/A33 
D273-10B/A48 X D22/A16 
o/iJR X o/iJR 
D273-10B/A68 X C021-1A 
Colonies Nurober Fraction 
scored of recoro-
sensitive bined 
colonies 
7265 0 0 
4979 3 0.06 
5814 8 0.14 
7231 9 0.12 
6100 3 0.05 
9045 6 0.07 
5814 6 0.1 
8687 1 a 0.01 
7880 0 0 
10635 0 0 
832 0 0 
2199 0.05 
175 16 9.1 
164 21 12.8 
211 11 5 
217 19 8.7 
138 7 5.1 
2847 0.035 
• Since the mutations in D273-10B/A31 and D273-10B/A33 
have been shown in this study to cause the saroe aroino acid Sub-
stitution we cannot account for the single sensitive colony. A pos-
sible explanation is that the A31 or A33 allele may have a low 
frequency of reversion which produced a sensitive segregant. 
combinational analysis in crosses to the standard 
testers; D22/A16 (olil), D22/A15 (oli2) and D22/V61 
(oli3). The results of the crosses are summarized in 
Table 4. No sensitive recombinants were found among 
diploids scored in the cross of D22/ A 16 to 0273-1 OB/ 
A21. This mutant also did not exhibit any cross-
resistance to venturicidin and was therefore assigned 
to the olil locus. In view of the rather large number 
of mitotic segregants scored (more than 7000), the 
Mutant A TPase Proteolipid 
results suggest that the mutation in D273-10B/A21 
and D22/A16 are either in the same or very closely 
linked alleles. The three other strains (D273-10B/A31, 
D273-10B/A32 and D273-10B/A33) were also charac-
terized as olil-resistant mutants. These strains were 
not cross-resistant to venturicidin but produced a low 
percentage of sensitive recombinants when crossed to 
D22/A16 or D273-10B/A21 (0.06-0.14%). Crosses 
of the latter three mutants in pairwise combinations, 
failed to yield recombinants with the exception of 
one sensitive co]ony that was scored in the cross of 
D273-10B/A31 to CD33-9A (this is a constructed 
strain containing the mutated allele of D273-10B/ 
A33). Based on these recombination data, the muta-
tions in D273-10B/A31, A32 and A33 are either in 
the same or closely linked alleles. All three mutants, 
however, are genetically distinct from D22/A16 and 
D273-10B/A21. 
Among the spontaneaus resistant clones isolated 
from D273-10B/A1, several were found to be cross-
resistant to venturicidin. This phenotype is character-
istically associated with mutations in the oli3 locus 
and one of the strains (D273-10B/A68) was chosen 
for further study. In the cross of D273-10B/A68 to 
D22/V61, a standard oli3 resistant mutant [13], only 
one sensitive recombinatant was observed in over 
2000 diploids scored. The mutated allele in D273-
10B/A68 was therefore tentatively assigned to the oli3 
locus. It is of interest that in our studies, the frequency 
of recombination between olil and oli3 as exemplified 
by the cross of D273-10B/A68 to CD21-1A is con-
siderably lower than reported by other laboratories. 
Using other olil and oli3 resistant strains, Lancashire 
etal. [13] and Trembathetal. [19] have measured 
recombination frequencies as high as 1.5% between 
the two loci. 
One of the resistant mutants, D273-10B/A48 was 
found to have a mutation in oli2. This strain was not 
cross-resistant to venturicidin and did not yield sensi-
tive recombinants when crossed to the oli2 tester 
D22/A15. The assignment ofthe mutated allelein A48 
to the oli2 ]ocus has been confirmed by crosses to 
other oli2 resistant strains (Dr W. Lancashire, private 
communication). 
Although we have not carried out an extensive 
analysis of inter-locus crosses, data based on rather 
small numbers of colonies scored indicate only weak 
linkage of the o/il-resistant alleles of D273-10B/A21, 
A31 and A33 with the oli2 marker of D22/A15 
(Table 4). 
Sequence Analyses of the Dicyclohexyl-
carbodiimide-Binding Proteolipid lso/ated 
from oli1, oli2 and oli3 Resistant Mutants 
In order to identify possible changes in the primary 
structure ofthe dicyclohexylcarbodiimide-binding pro-
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8-1 B-2 B-3 B-4 
BPT-1 BPT-2 
Fig.l. Amino acid sequence of the dicyclohexylcarbodiimide-bimling profein of the AT Pase-complex of Saccharomyces cerevisiae, strain 
D273-JOB. The fragments B-1 to B-4 were obtained after cleavage with cyanogen bromide. The fragments BPT-1 and BPT-2 are tryptic 
peptides prepared from a pepsin digest of fragment of B-2. The amino acid residues are represented by a one-letter code according 
to the convention of [20]. The inhibitor dicyclohexylcarbodiimide is covalently bound to the glutamyl residue 59 marked by an arrow [21] 
Table 5. Amino acid composition of cyanogen bromide fragment B-2 of the dicyc/ohexylcarbodiimide-binding protein from oligomycin-resistant 
strains 
Aminoacid Number of residues in strain 
-----·---· 
wild type D273-10B D273-10B 0273-lOB D273-10B 0273-tOB 0273-lOB 
A21 A31 
molfmol 
Aspartic acid 3.11 3.08 3.07 
Threonine 1.97 2.07 2.09 
Serine 2.92 2.86 3.16 
Glutamic acid 0.99 1.17 1.10 
Proline 1.95 2.25 2.02 
Glycine 7.35 7.15 7.35 
Alanine 6.85 6.33 6.67 
Valine 3.06 3.33 3.69 
Isoleueine 6.2 6.22 6.53 
Leueine 5.24 5.09 5.18 
Phenylalanine 1.84 1.79 1.97 
Tyrosine 0.87 1.04 1.04 
Lysine 1.96 1.97 1.82 
Arginine 1.11 1.11 0.98 
Homoserine + + + 
tein of the oligomycin-resistant mutants, the structural 
analyses were limited to the cyanogen bromide cleavage 
products which could be easily obtained following 
chromatography of the total digest on BioGel P30. 
Sinee amino acid analyses of the cyanogen bromide 
fragments were sufficiently sensitive to detect single 
amino acid substitutions, amino acid compositions 
were initially determined for each ofthe three cyanogen 
bromide fragments. In the case of the proteins isolated 
from the oligomyein-resistant strains, the eompositions 
of fragments B-2 and B-4 ( ef. Fig. 1) were in eaeh 
ease found to be indistinguishable from that of the 
wild-type within the Iimits of experimental error 
(Table 5), and they were not further sequenced. Frag-
ment B-3 eontaining the sequenee from residues 51-
67, however, showed clear eompositional differenees 
from the corresponding wild-type peptide for the 
four olil and one oli3 mutants examined (Table 6). 
The fragment of the D273-10B/A21 protein had one 
less leueine and an additional phenylalanine. The B-3 
fragments of the other three olil resistant strains, 
A32 A33 A68 A48 
··- ·-·----·· ·---·· --·---
3.0 3.03 3.01 3.08 
1.9 2.08 2.13 2.08 
2.8 3.08 3.13 2.96 
1.0 1.18 0.97 1.15 
1.9 2.21 2.13 2.11 
6.9 6.88 7.06 7.05 
6.5 6.58 6.33 6.38 
3.5 3.62 3.35 3.38 
6.6 6.43 6.28 6.73 
4.9 4.86 4.87 5.04 
2.3 1.78 1.56 1.72 
1.2 1.07 0.98 0.99 
1.7 1.79 2.02 1.93 
0.9 0.97 1.09 1.06 
+ + + + 
D273-1 OB/ A31, A32 and A33, eaeh were missing the 
single eysteine, measured as cysteic acid, and had an 
extra serine. The composition of fragment B-3 from 
the oli3 resistant mutant D273-10B/A68 indieated the 
loss of one leueine and the appearance of an extra 
valine whieh is absent in the wild-type peptide. No 
differences were noted in the eomposition of the B-3 
fragment of the o/i2 resistant mutant D273-10B/A48. 
The amino aeid changes seen in the composition 
of the cyanogen bromide fragments were confirmed 
by solid-phase sequencing. The sequence data also 
permitted an exact identification ofthe residue position 
at which the amino acid Substitution oecurred. This 
is summarized in Fig. 2 for both the olil and oli3 
resistant mutants. In D273-10B/A21 a phenylalanine 
is substituted for leueine at position 53 of the se-
quence. Mutants D273-10B/A31, A32 and A33 have 
identieal substitutions of a serine for cysteine at posi-
tion 65. The oli3 mutation in D273-1 OB/ A68 oceurs 
at the intervening residue 57, where a leueine is re-
plaeed by a valine. The sequenee of the fragment 
604 Mutant A TPase Proteolipid 
Table 6. Amino acid composition of cyanogen bromide peptide B-3 of the dicyclohexy/curbodiimide-binding protein from wild-type and mutam 
strains 
The integral numbers were obtained by sequence analysis. The values in parenthesis were determined by amino acid analysis 
Aminoacid Nurober of residues in strain 
D273-10B D273-10B D273-10B 0273-lOB D273-10B 0273-tOB D273-10B M339-45 
Al A21 A31 A32 A33 A68 A48 R17 
moljmol 
Cysteic acid 1 (0.65) 1 (0.45) 0(- ) 0(- ) 0(- ) 1 (0.62) 1 (0.68) 1 (0.44) 
Threonine 1 (0.95) 1 (0.96) 1 (1.00) 1 (1.00) 1 (0.99) 1 (1.02) t (0.95) 1 (0.98) 
Serine 1 (1.14) 1 (1.11) 2 (1.98) 2 (1.90) 2 (1.89) 1 (1.09) 1 (1.26) t (1.08) 
Glutamic acid 1 (0.98) 1 (0.99) 1 (1.04) 1 (1.10) 1 (1.01) 1 (0.88) 1 (0.91) t (0.98) 
Glycine 2 (2.04) 2 (1.98) 2 (2.00) 2 (1.99) 2 (1.99) 2 (2.06) 2 (2.20) 2 (2.03) 
Alanine 3 (2.76) 3 (2.77) 3 (3.05) 3 (3.00) 3 (2.94) 3 (3.17) 3 (2.86) 3 (2. 76) 
Valine 0 (-) 0 ( -) 0 (-) 0 (-) 0 (-) 1 (1.17) 0 (-) 0 (-) 
Isoleueine 1 (1.16) 1 (0.98) 1 (0.95) t (0.92) 1 (1.03) 1 (0.93) 1 (1.27) 1 (1.00) 
Leueine 4 (3.84) 3 (3.14) 4 (3.94) 4 (4.10) 4 (4.31) 3 (3.01) 4 (3.65) 4 (3.64) 
Phenylalanine 2 (2.04) 3 (3.02) 2 (2.25) 2 (1.98) 2 (1.53) 2 (2.40) 2 (2.09) 2 (2.11) 
Homoserine 1 ( +) 1 ( +) t ( +) 1 ( +) 1 ( +) 1 ( +) 1 ( +) 1 (+) 
51 53 57 65 
Wild type 0273-108 -Ala- Ile -Leu-Gly-Phe -Ala-Leu -Ser-Glu-Ala-Thr-Gly-Leu-Phe -Cys-Leu-Met-
Mutant 0273-108 I A 21 - Ala- Ile-Phe-Gly- Phe- Ala-Leu- Ser- Glu-Ala-Thr-Gly- Leu-Phe-Cys-Leu-Met-
0273-108/A31 - Ala -lle-Leu-Gly -Phe- Ala -Leu-Ser-Glu-Ala- Thr- Gly-Leu-Phe-Ser-Leu-Met-
A32 
A33 
0273-108/ A68 -Aia-lle-Leu-Gly-Phe-Aia- Vai-Ser -Glu-Ala- Thr-Gly-Leu-Phe-Cys -Leu -Met-
40 42 
Wild type 0273-108 -Asn- Pro-Ser -lle-lys-Asp-
Revertant M339-4S/R17 -Asn-Pro-1:.!.!!,-lle-Lys-Asp-
Fig. 2. Altered amino acid sequences of the dicydohexylcarhodiimide-binding protein from olit and oli3 resistant mutants and the mir 
revertant M339-45 
from o/i2-resistant mutant D273-10B/A48, which was 
determined as a control, was found tobe unaltered. 
Analysis of the Dicyclohexylcarbodiimide-
Binding Protein in a Revertant of a pho2 Mutant 
Previous studies have shown that mutations in the 
pho2 locus cause a deficiency of the oligomycin-
sensitive ATPase (14]. Since mutations in this locus 
are closely linked to the olil resistance marker and 
result in a molecularly altered form of the dicyclo-
hexylcarbodiimide-binding protein, it was proposed 
that pho2 mutational sites are also in the structural 
gene of this protein [14). To verify this conclusion 
we have analyzed the amino acid composition and 
sequence of the protein isolated from a revertant of 
the pho2 mutant M 339-45. This revertant (M339-45/ 
R 17) is oligomycin resistant and grows on glycerol 
with a generation time Ionger than the wild-type. lt is 
therefore probable that M339-45/R17 contains a 
sccond correcting mutation (supressor mutation). 
Genetic tests on the revertant have shown that the 
correcting mutation is cytoplasmically inherited and 
is probably intragenic since it was not readily geneti-
cally dissectable from the original mit- mutation [14]. 
Amino acid analyses of the dicyclohexylcarbo-
diimide-binding protein of M339-45/R17 indicate that 
fragments B-3 (Table 6) and B-4 are indistinguishable 
from the wild-type. This was confirmed by sequencing 
the two fragments. Thecyanogen bromidefragment B-2 
containing residues 2-50, however, was found to 
differ from the corresponding wild-type peptide with 
respect to the number of serine and leueine residues 
(Table 7). A partial sequence of the B-2 fragment 
indicated that residues 2- 35 are identical with the 
wild type. After cleavage of fragment B-2 with pepsin, 
a peptide containing residues 31-45 was isolated. 
This peptic fragment was digested with trypsin and 
the fragments BPT-1 and BPT-2 were obtained [11] 
(see Fig.1). Fragment BPT-1 showed the same amino 
acid composition as the corresponding wild-type 
peptide, whereas fragment BPT -2 lacked serine and 
had an additionalleueine (Table 7). Sequencing ofthis 
fragment revealed that the serine in position 42 is 
substituted by a leueine (Fig. 2). This serine/leucine 
exchange probably resulted from two separate muta-
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Table 7. Aminoacid composition ojfragments ofthe dicyclohexylcarbodiimide-binding proteinfrom the pho2 revertant strain M339-45/Rl7 
The ~ya~og~n bromide fragment B-2 was treated with pepsin. A peptide fragment containing residues 31 -45 was further cleaved with 
~ryp~m y1eldmg fragments BPT-t and BPT-2. The procedures will be described in a forthcoming paper. The origin of the fragments is shown 
m F1g.l 
Aminoacid Number of residue in fragments 
B-2 
wild type M339-45/R 17 
mol/mol 
---... 
Aspartic acid 3.11 3.44 
Threonine 1.97 2.07 
Serine 2.92 1.25 
Glutamic acid 0.99 1.22 
Praline 1.95 2.10 
Glycine 7.35 7.30 
Alanine 6.85 6.90 
Valine 3.06 3.20 
Isoleueine 6.20 6.50 
Leueine 5.24 6.00 
Phenylalanine 1.84 2.25 
Tyrosine 0.87 0.90 
Lysine 1.96 1.93 
Arginine 1.11 0.98 
Homoserine + + 
. tions, since the correcting mutation of the revertant 
appears to be located in the same gene as the original 
miC mutation (see above) and since no other altera-
tions could be detected in the revertant proteolipid. 
DISCUSSION 
Prior genetic and biochemical studies suggested 
that the o/il and pho2 genetic markers of the yeast 
mitochondrial genome are located in the structural 
gene of the dicyclohexylcarbodiimide-binding protein 
[10, 14]. This was confirmed for the olil marker by 
amino acid sequence analysis of the protein isolated 
from wild type and the o/il-resistant mutant D273-
10B/A21 [22]. In the present study we have sequenced 
the dicyclohexylcarbodiimide-binding protein from 
several different olil as well as oli2 and oli3 resistant 
mutants and from a revertant of a pho2 mutant. 
With the exception of the oli2 resistant strain 
whose protein showed no compositional differences 
to the wild type, all the other proteins examined were 
found to have altered primary structures. The amino 
acid sequence data conclusively localize the olil, oli3 
and pho2 loci in the structural gene of the dicyclo-
hexy lcarbodiimide-binding protein of the yeast A TPase 
complex. The amino acid substitutions in the proteins 
of the olil and oli3 resistant strains can be explained 
by single base changes in the mitochondrial DNA. 
In the case of the pho2 revertant, it is necessary to 
invoke two separate mutations in the same codon, 
the first causing the ATPase deficiency in the mit-
---·- -------·---·-
BPT-1 BPT-2 
-----·---
wild type M339-45/R17 wild type M339-45/R17 
1.10 1.33 2.00 1.87 
1.00 0.42 1.04 0.00 
0.78 0.98 
1.10 1.17 
2.00 1.88 
1.04 0.96 
1.05 1.06 1.04 1.13 
0.99 1.02 0.00 0.96 
0.84 1.01 
0.98 0.91 
mutant M339-45 and the second correcting the original 
mutation. 
The identification of an oli3 mutation in the 
structural gene of the dicyclohexylcarbodiimide-bind-
ing protein is somewhat unexpected. oli3-resistant 
mutants are characterized by cross-resfstance to ven-
turicidin [13]. The D273-10B/A68 strain was ascer-
tained to be cross-resistant to venturicidin and to 
have a mutation tightly linked to another standard 
oli3 mutation (D22/V61). The fact that D273-10B/A68 
gave less than 0.1 % sensitive recombinants when 
crossed to an o/il-resistant mutant is inconsistent 
with previous reports that the recombination frequen-
cies between olil and oli3 range from 0.5-1.5% [13, 
19]. There are several possible explanations for this 
discrepancy. (a) The D273-10B strain may in general 
have lower recombination frequencies than other yeast 
strains. (b) The structural gene of the dicyclohexyl-
carbodiimide-binding protein may have an insertion 
between the olil and oli3 loci in some yeast strains. 
(c) There may be another genein yeast mitochondrial 
DNA which contains allele(s) that confer oligomycin 
and venturicidin resistance. The latter possibility gains 
some support from the studies of Groot-Obbink et al. 
(23] who have found an altered form of subunit 6 of 
the A TPase complex in a temperature-sensitive o/iJ-
resistant mutant. 
The identification of the amino acid substitutions 
in the polypeptide chains of the mutant proteins allow 
the recombination frequencies to be correlated with 
the distances between the altered amino acids. Crosses 
of the A31, A32 or A33 mutants to the A21 strain 
606 
produced 0.06-0.14% wild-type recombinants. When 
the results of the three crosses are pooled an average 
recombination frequency of0.11 % is obtained between 
the two mutations. The A21 strain has an amino acid 
substitution at position 53 which is 12 residues away 
from the amino acid exchange in A31, A32 and A33. 
Thus, the average recombination frequency per amino 
acid residue is approximately 0.01 %. A similar value 
is obtained from the cross of A21 to A68 where the 
mutations are four amino acids apart. The percentage 
of sensitive recombinants scored in the latter cross 
was 0.05 %. Assuming co-linearity of the structural 
gene and the absence of polar effects, the maximal 
recombination frequency for mutation in the most 
distaut amino acids of this 76-residue polypeptide is 
0.8%. 
The dicyclohexylcarbodiimide-binding protein is a 
subunit of the membrane factor of the A TPase-
complex of mitochondria [24- 26], chloroplasts [27] 
and bacteria [28- 30]. Although the precise function 
of this protein in the catalytic mechanism of the 
A TPase is not known, there is considerable evidence 
suggesting that it acts as a protonophore and that it 
provides binding sites for certain inhibitors of the 
enzyme. Dicyclohexylcarbodiimide, a potent inhibitor 
of oxidative phosphorylation and of the A TPase has 
been shown to bind covalently to the glutamyl residue 
at position 59 of the yeast protein [21 ]. There is also 
evidence that oligomycin reacts with an amino group 
on the protein to form a Schiff base. Criddle et al. [31] 
have reported that the dicyclohexylcarbodiimide-bind-
ing protein of yeast is labeled with [3 H]borohydride 
in the presence but not absence of oligomycin. Further-
more, the protonophoric activity of the protein was 
inhibited by oligomycin when it was isolated from 
wild type but not oligomycin-resistant mutants [32]. 
The isopolar Substitutions leucinejphenylalanine 
(residue 69), leucine/valine (residue 42) identified in 
this study, each gives rise to the oligomycin-resistance 
phenotype. The functional properties of the ATPase 
complex do not appear to be affected by the mutations 
since the cell mass yield of the mutants is similar to 
that of the wild type. The mit- revertant, M339-45/ 
R17, however, has a slightly Ionger generation time. 
Resistance of the mutant ATPase to oligomycin is 
most simply explained by an alteration of the binding 
site resulting in a lowered affinity for the inhibitor. 
The amino acid exchanges detected so far in the oligo-
mycin~resistant strains span residues 42- 65 of the 
polypeptide chain. Oligomycin-resistant mutants of 
Neuraspara crassa have also been shown to have 
amino acid substitutions in the same region of the 
protein [33]. It is also of interest that some of the 
mutations occur at positions which are near to the 
glutamyl residue involved in dicyclohexylcarbodiimide-
binding. These data suggest that the amino acid side 
chains of the residues affected in the mutant proteins 
Mutant ATPase Proteolipid 
may be located at the surface ofthe ATPase membrane 
factor (protein-lipid interphase) and that they are part 
of the binding site for oligomycin. 
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